Evidence map›Paper›PMID 38402259›Full record

ArticleScientific reports2024

Beam quality and the mystery behind the lower percentage depth dose in grid radiation therapy.

Amir Hossein Karimi, Indra J Das, Nahid Chegeni, Iraj Jabbari, Fatemeh Jafari, Ghazale Geraily

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Amir Hossein KarimiDepartment of Medical Physics and Biomedical Engineering, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-1598-8934
Indra J DasDepartment of Radiation Oncology, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. indra.das@nm.org.ORCID 0000-0003-4094-0892
Nahid ChegeniDepartment of Medical Physics, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Iraj JabbariDepartment of Nuclear Engineering, Faculty of Physics, University of Isfahan, Isfahan, Iran.
Fatemeh JafariRadiation Oncology Department, Cancer Institute, Imam-Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Ghazale GerailyDepartment of Medical Physics and Biomedical Engineering, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. gh-geraily@sina.tums.ac.ir.ORCID 0000-0003-2616-5586
Imam Khomeini Hospital · IRAhvaz Jundishapur University of Medical Sciences · IRIran University of Medical Sciences · IRNorthwestern University · USUniversity of Isfahan · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Grid therapy recently has been picking momentum due to favorable outcomes in bulky tumors. This is being termed as Spatially Fractionated Radiation Therapy (SFRT) and lattice therapy. SFRT can be performed with specially designed blocks made with brass or cerrobend with repeated holes or using multi-leaf collimators where dosimetry is uncertain. The dosimetric challenge in grid therapy is the mystery behind the lower percentage depth dose (PDD) in grid fields. The knowledge about the beam quality, indexed by TPR

Indexed as

PhotonsRadiometryElectronsMonte Carlo MethodParticle AcceleratorsPhantoms, ImagingRadiotherapy DosageRadiotherapy Planning, Computer-AssistedGrid therapyLinacMonte CarloSmall field dosimetrySpectrometry

Identifiers

PMID38402259
PMCPMC10894234
OpenAlexW4392131556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.